INSIGHTS ON CELL & GENE COMMERCIALIZATION ISSUES
-
![Ori Biotech - Arif]( "Ori Spotlight: Investor Confidence In Advanced Therapies Is Critical For Long-Term Success")
Ori Spotlight: Investor Confidence In Advanced Therapies Is Critical For Long-Term SuccessEndpoints News founder Arsalan Arif shares his journey and unpacks the cell and gene therapy market, from investor sentiment to the challenges of scaling innovation.
-
![teamwork, strategy, communication-GettyImages-474406440]( "Commercializing Your First Cell Or Gene Therapy (CGT): Developing Your Market Access Strategy")
Commercializing Your First Cell Or Gene Therapy (CGT): Developing Your Market Access StrategyEffectively commercializing cell and gene therapies requires a strong market access strategy. Learn key steps for ensuring your therapy reaches patients at the right time and place.
-
![InspiroGene - integrated services]( "Integrated Services: Expertise At Every Step")
Integrated Services: Expertise At Every StepBringing cell and gene therapies to market is complex, but with the right partner, you can overcome challenges and simplify, support, and scale your therapy from development to commercialization.
-
![Business Team Climbing, Leadership, Growth, Unity-GettyImages-2114194800]( "How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction")
How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory FrictionIndustry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.
-
![Ori Biotech - Julie Allickson]( "Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access")
Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient AccessA pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.
-
![GettyImages-1224202684-laboratory-dna-scientist-research-monitoring]( "Perspectives And Projections On The 2025 Biotech Landscape")
Perspectives And Projections On The 2025 Biotech LandscapeListen to Aditya Kotta discuss key biotech trends, from post-COVID market shifts to global R&D and investment strategies, as well as China’s rising role in pharmaceutical innovation.
-
![Amgen Building-GettyImages-1418324349]( "Amgen Bets On Agility In The Age Of AI")
Amgen Bets On Agility In The Age Of AIThe company is speeding up process optimization with tools like predictive analytics, digital twins, and generative AI copilots.
-
![Strategic Logistics]( "Crafting Scalable Solutions For Maximum Reach And Success")
Crafting Scalable Solutions For Maximum Reach And SuccessIs your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
![Maximizing Impact]( "Maximizing Impact: Strategies For Building Robust Patient Support Programs")
Maximizing Impact: Strategies For Building Robust Patient Support ProgramsPanelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.
-
![The Power Of Integrated Distribution Strategies]( "The Power Of Integrated Distribution Strategies")
The Power Of Integrated Distribution StrategiesDiscover the power of integrated distribution for cell and gene therapies. Learn from expert speakers how adaptable partnerships can successfully bring these innovative treatments to more patients.
